Commercialization of Tissue-Based Research: Time to Move Beyond the Gift/Market Dichotomy

Dickenson D. Property in the Body: Feminist Perspectives. New York: Cambridge University Press; 2007.

Laurie G. Genetic Privacy. A Challenge to Medico-Legal Norms. Cambridge: Cambridge University Press; 2002.

Hoeyer K. Exchanging Human Bodily Material: Rethinking Bodies and Markets. New York: Springer; 2013.

Sharp LA. Bodies, Commodities, and Biotechnologies. Death, Mourning, and Scientific Desire in the Realm of Human Organ Transfer. New York: Columbia University Press; 2007.

Dixon-Woods M , Wilson D , Jackson CJ , Cavers D , Pritchard-Jones K. Human tissue and 'the public': The case of childhood cancer tumour banking. BioSocieties, 2008; 3:57–80.

Hoeyer K. Tradable body parts? How bone and recycled prosthetic devices acquire a price without forming a 'market'. BioSocieties, 2009; 4:239–256.

Hoeyer K. Conflicting notions of personhood in genetic research. Anthropology Today, 2002; 18(5):9–13.

Goodwin M. Black Markets: The Supply and Demand of Body Parts. New York: Cambridge University Press; 2006.

Taylor J. Stakes and Kidneys. Why Markets in Human Body Parts Are Morally Imperative. Hampshire, UK: Ashgate; 2005.

Satel S. Introduction. In: Satel S , editor. When Altruism Isn't Enough. The Case for Compensating Kidney Donors. Washington DC: The AEI Press; 2008. p. 1–10.

Parry B. Entangled exchange: Reconceptualising the characterisation and practice of bodily commodification. Geoforum, 2008; 39:1133–1144.

Clark BJ , Baust JM , Stacey G. How much will biobanking industry come to rely on private companies?. Biopreserv Biobanking, 2010; 8:179–180.

Evers K , Forsberg J. What are your views on commercialization of tissues for research? “The best possible use”: Against commercilization of tissue samples. Biopreserv Biobanking, 2012; 10:476–477.

Hoeyer K , Schicktanz S , Deleuran I. Public attitudes to financial incentive models for organs: a literature review suggests that it is time to shift the focus from 'financial incentives' to 'reciprocity'. Transplant Intern, 2013; 26:350–357.

Patra PK , Sleeboom-Faulkner M. Informed consent and benefit sharing in genetic research and biobanking in India: Some common impediments in practice. In: Dabrock P , Taupitz J , Ried J , eds. Trust in Biobanking. Heidelberg: Springer; 2012. p. 237–256.

Kowal E , Radin J , Reardon J. Indigenous body parts, mutating temporalities, and the half-lives of postcolonial technoscience. Social Studies Sci, 2013; 43:465–483.

Hayden C. Taking as giving: Bioscience, exchange, and the politics of benefit-sharing. Social Studies Sci, 2007; 37:729–758.

Stegmayr B , Asplund K. Informed consent for genetic research on blood stored for more than a decade: A population based study. BMJ, 2002; 325:634–635.

Steinsbekk KS , Ursin LØ , Skolbekken J-A , Solberg B. We're not in it for the money—lay people's moral intuitions on commercial use of ‘their’ biobank. Medicine, Health Care and Philosophy, 2011; 16(2):151–162.

Winickoff D , Neumann L. Towards a social contract for genomics: Property and the public in the 'biotrust' model. Genomics, Society and Policy, 2005; 1(3):8–21.

Anderlik MR. Commercial biobanks and genetic research: Ethical and legal issues. Am J Pharmacogenomics, 2003; 3:203–215.

Sahlins M. Stone Age Economics. New York: Aldine Artherton; 1972.